Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-65206-z
Affiliations:
9
Authors:
18
Go to article
Institutions Authors Share
The First Affiliated Hospital, SYSU, China
17.000000
17.000000
 0.94
Shenzhen Qianhai Taikang Hospital, China
1.000000
 0.06
Interested in Oncology and Carcinogenesis?